Related Experiment Video
Updated: Jun 4, 2026
06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Genome-wide association studies in multiple sclerosis: lessons and future prospects
Anu Kemppinen1, Stephen Sawcer, Alastair Compston
1Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, UK. ak635@medschl.cam.ac.uk
Briefings in Functional Genomics
|February 12, 2011
Summary
Genome-wide association studies (GWAS) have identified 16 significant genetic loci associated with multiple sclerosis (MS) risk. Further research is ongoing to uncover additional genetic factors contributing to this complex neurodegenerative disease.
Area of Science:
- Neuroimmunology
- Genetics
- Complex Disease Etiology
Background:
- Multiple sclerosis (MS) is an inflammatory neurodegenerative disease with a significant genetic component.
- A major histocompatibility complex (MHC) haplotype is the primary known genetic risk factor.
- Previous genetic studies identified limited risk variants until the advent of genome-wide association studies (GWAS).
Purpose of the Study:
- To identify and confirm genetic risk variants for multiple sclerosis (MS).
- To explore the role of both immunological and neurological genes in MS pathogenesis.
- To investigate the functional impact of identified genetic variants.
Main Methods:
- Conducted multiple genome-wide association studies (GWAS) in MS populations.
- Performed follow-up studies to confirm genome-wide significant loci.
- Utilized pathway analyses to investigate modestly associated variants.
Main Results:
- Confirmed 16 loci associated with MS at genome-wide significance through 10 GWAS and follow-up studies.
- Identified common risk variants often located near genes with key immune functions, frequently overlapping with other autoimmune diseases.
- Pathway analyses suggested involvement of neurological genes among modestly associated variants.
Conclusions:
- Genetic factors play a crucial role in multiple sclerosis susceptibility.
- Identified variants are predominantly linked to immune function, but neurological genes are also implicated.
- Further research is essential to elucidate the precise mechanisms of these variants and identify remaining genetic risk factors for MS.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...